Last reviewed: July 8, 2026
Last updated: July 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and reducing appetite signals in the brain, helping patients lose an average of 15% body weight within 68 weeks. A common question from people considering this therapy is whether they'll need to continue medication indefinitely, or if they can eventually stop and maintain their results. The reality involves several phases of treatment and depends on individual factors.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Long Most People Stay on Semaglutide Treatment
Clinical trials and real-world data show that most patients who achieve significant weight loss benefit from staying on semaglutide for at least 1–2 years of active treatment. During this time, the medication helps reset hunger signals and supports new eating habits. PlexusDx offers flexible commitment tiers so patients can adjust their treatment duration based on progress and clinical guidance from their provider.
Studies demonstrate that stopping semaglutide without lifestyle changes often leads to weight regain, as appetite hormones gradually return to their baseline levels. This doesn't mean failure—it reflects how the medication works. Many patients choose to continue treatment because the long-term benefits outweigh the cost of stopping and potentially regaining weight.
Weight Regain After Stopping Semaglutide: What Research Shows
Research published in major obesity journals shows that approximately 50–80% of weight lost is regained within one year after discontinuing GLP-1 therapy, if diet and exercise habits don't change significantly. This rebound effect isn't unique to semaglutide—it's a metabolic reality with most weight loss interventions. The key difference is that staying on therapy prevents this cycle.
Some patients successfully maintain weight loss after stopping if they've established durable lifestyle changes, such as consistent exercise, sustained dietary shifts, and ongoing behavioral support. PlexusDx providers can help determine whether your personal habits and metabolism support maintenance after treatment ends, or whether continued therapy is the more realistic long-term strategy.
Maintenance Dosing vs. Active Weight Loss Phases
Semaglutide treatment typically follows two phases: an active weight loss phase (weeks 1–68), where dose gradually increases, and a maintenance phase, where dosing stabilizes and the goal shifts from rapid weight loss to preventing regain. During maintenance, many patients use lower or stable doses that still suppress appetite but at a reduced intensity. PlexusDx compounded semaglutide injection pricing remains flat at your chosen tier regardless of dose level—your dose may need to go up, but your price won't.
Maintenance can last months or years, depending on your goals and how your body responds. Some patients move to intermittent dosing or lower frequencies once their weight stabilizes. Your provider will work with you to find the minimum effective dose that keeps you feeling satisfied and prevents creeping weight regain.
Personalization: Genetic Insights for Long-Term Success
The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Understanding your genetic predispositions allows PlexusDx providers to optimize your treatment strategy early. Patients with certain GLP-1 receptor variants may respond better to higher doses or longer duration, while others achieve excellent results with lower maintenance dosing. This personalization increases the likelihood that your long-term treatment plan matches your actual biology, not a one-size-fits-all protocol.
Cost Considerations Over One, Two, and Five Years
At PlexusDx, compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no per-dose increases as your therapy evolves. Over one year, that's approximately $1,788; over two years, roughly $3,576; and over five years, about $8,940. Compare this to the medical costs of untreated obesity—increased risk of type 2 diabetes, cardiovascular disease, and joint problems—which far exceed medication costs over the same timeframe.
PlexusDx medications are HSA/FSA eligible, which reduces out-of-pocket costs for eligible patients. No membership fee, no insurance requirement, and no hidden charges. Flexible commitment tiers let you start with monthly payment and adjust if your provider recommends longer-term therapy, making the financial planning straightforward.
When Some Patients Successfully Stop Semaglutide
A minority of patients—roughly 10–20% in observational data—successfully maintain significant weight loss after stopping semaglutide, particularly if they've made durable lifestyle changes, developed consistent exercise habits, and fundamentally shifted their relationship with food. These individuals usually stay on treatment for 18–36 months and then transition off with close monitoring. Stopping works best when done gradually under medical supervision, not abruptly.
Your PlexusDx provider will track your progress, hunger levels, and weight stability to determine if you're a candidate for discontinuation. If regain begins, restarting semaglutide is straightforward and effective, with no loss of responsiveness. Many patients view long-term therapy as a chronic disease management tool, similar to blood pressure or diabetes medication—necessary for ongoing health but not a sign of personal failure.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Will I have to take semaglutide forever?
Not necessarily. Most patients benefit from 1–2 years of continuous treatment, followed by a maintenance phase with stable or lower dosing. Some patients successfully stop after establishing durable lifestyle changes, while others choose long-term therapy to prevent weight regain. Your PlexusDx provider will help determine the right duration for your situation.
What happens to my weight if I stop semaglutide?
Research shows that 50–80% of weight loss is typically regained within one year after stopping, unless diet and exercise habits have changed significantly. This is a biological reality, not a personal failure. Restarting semaglutide is effective if regain occurs.
How much does semaglutide cost per month at PlexusDx?
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with pricing remaining flat across dose levels—your dose may need to go up, but your price won't. No membership fee or insurance required, and HSA/FSA eligible.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Is it safe to stay on semaglutide for years?
Yes. Long-term safety data from clinical trials and real-world use supports years of continuous semaglutide treatment. Side effects often decrease over time as your body adjusts. Your PlexusDx provider will monitor you regularly to ensure the medication continues to be safe and effective for you.
What's the difference between active weight loss and maintenance dosing?
Active weight loss phases involve gradually increasing doses over 12–16 weeks, while maintenance uses a stable dose designed to prevent regain rather than drive further loss. Maintenance dosing is often lower and can last months or years depending on your goals.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Happens If You Skip a Week of Zepbound?
What Foods to Avoid on Wegovy: A Comprehensive Guide